(Q44091802)

29 November 2017

title

Impact of furazolidone-based quadruple therapy for eradication of Helicobacter pylori after previous treatment failures (English)

1 reference

29 November 2017

1 reference

Treiber G

1

1 reference

29 November 2017

Ammon S

series ordinal

2

1 reference

29 November 2017

Malfertheiner P

series ordinal

3

1 reference

29 November 2017

Klotz U

series ordinal

4

1 reference

29 November 2017

publication date

1 August 2002

1 reference

29 November 2017

1 reference

29 November 2017

volume

7

1 reference

29 November 2017

issue

4

1 reference

29 November 2017

page(s)

225-231

1 reference

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2002.00087.X

Regular review: treatment of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2002.00087.X

A systematic review of Helicobacter pylori eradication therapy--the impact of antimicrobial resistance on eradication rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2002.00087.X

Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2002.00087.X

Furazolidone- and nitrofurantoin-resistant Helicobacter pylori: prevalence and role of genes involved in metronidazole resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2002.00087.X

Clarithromycin vs. furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2002.00087.X

A multicentre study on eradication of Helicobacter pylori using four 1-week triple therapies in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2002.00087.X

Furazolidone versus metronidazole in quadruple therapy for eradication of Helicobacter pylori in duodenal ulcer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2002.00087.X

Furazolidone-containing short-term triple therapies are effective in the treatment of Helicobacter pylori infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2002.00087.X

High cure rate of Helicobacter pylori infection using tripotassium dicitrato bismuthate, furazolidone and clarithromycin triple therapy for 1 week.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2002.00087.X

In vitro selection of resistant Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2002.00087.X

Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2002.00087.X

Furazolidone combination therapies for Helicobacter pylori infection in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2002.00087.X

Relation between severity of liver disease and renal oxygen consumption in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2002.00087.X

High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2002.00087.X

Randomized study of two "rescue" therapies for Helicobacter pylori-infected patients after failure of standard triple therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2002.00087.X

Pooled analysis on the efficacy of the second-line treatment regimens for Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2002.00087.X

10.1046/J.1523-5378.2002.00087.X

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference